Search for: "GLAXOSMITHKLINE" Results 101 - 120 of 1,801
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Mar 2021, 6:00 am by Jason Rantanen
To the Open Source Hardware (OSHW) community, the Federal Circuit’s October opinion in the ongoing appeal of GlaxoSmithKline LLC v. [read post]
8 Mar 2021, 11:30 am by D Daniel Sokol
The Application of Competition Law to the Pharmaceutical Sector in the European Union David W Hull, Michael J Clancy Key Points In its seminal judgment in GlaxoSmithKline (paroxetine), the CJEU established the governing principles for assessing the compatibility of reverse-payment... [read post]
8 Mar 2021, 12:30 am by anne
GlaxoSmithKline whistleblower Cheryl Eckard, whose action alleging that the company knowingly sold contaminated baby ointment and an ineffective antidepressant resulted in a $750 million settlement. [read post]
3 Mar 2021, 12:04 pm by Michael Abramowicz
Covid-19 vaccines have been quite successful, but there have still been many failures, such as that of Sanofi and GlaxoSmithKline. [read post]
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
Amgen, GlaxoSmithKline (GSK) and a group of intellectual property professors filed a trio of amicus briefs placing their support behind Idenix, warning that the future of innovation was on the line. [read post]
22 Jan 2021, 2:00 am by Katharine Van Tassel
Carrier (Rutgers Law School), Matthew J Dowd, Robert Scheffel, Corrected Brief of Amici Curiae Fifty-Seven Law, Economics, Business, Health, and Medicine Professors in Support of Cross-Appellant's Petition for Rehearing En Banc, Federal Circuit brief in GlaxoSmithKline LLC v.... [read post]
20 Jan 2021, 9:50 am by Geoff Schweller
The Biden/Harris administration officially begins on January 20, 2021. [read post]
20 Jan 2021, 9:50 am by Geoff Schweller
The Biden/Harris administration officially begins on January 20, 2021. [read post]
15 Dec 2020, 12:21 pm by Dennis Crouch
Certified Aviation Services, LLC  (automation & eligibility) [EcoWashingMachine][CAFC Decision] GlaxoSmithKline LLC v. [read post]
15 Dec 2020, 12:15 pm by Rainer Winters
  Whistleblower revelations exposed corruption, insider trading and other violations from these European companies: Belgium: Anheuser-Busch  Estonia: Tallinex France: Société General, Sanofi, Total Italy: ENI  Netherlands: VimpelCom, Royal Dutch Shell, Koninklijke Philips Electronics Norway: Statoil  Poland: Biomet Russia: JSC VTB Banks, Mobile TeleSystems  Sweden: Telia, Ericsson Switzerland: Credit Suisse, Novartis  UK: GlaxoSmithKline,… [read post]
25 Nov 2020, 9:45 am by Steve Brachmann
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]
25 Nov 2020, 9:45 am by Steve Brachmann
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]
20 Nov 2020, 11:15 am by IPWatchdog
This week in Other Barks & Bites: the USPTO issues a final rule on trademark fee adjustments at the agency and also extends the public comment period for soliciting input on the agency’s exercise of discretion in institution trials at the PTAB; the UKIPO issues updates to post-Brexit rules narrowing acceptable Addresses for Service on agency filings; the Federal Circuit affirms a $90 million infringement verdict against GlaxoSmithKline’s sale of Ellipta inhalers, and rules… [read post]
20 Nov 2020, 11:15 am by IPWatchdog
This week in Other Barks & Bites: the USPTO issues a final rule on trademark fee adjustments at the agency and also extends the public comment period for soliciting input on the agency’s exercise of discretion in institution trials at the PTAB; the UKIPO issues updates to post-Brexit rules narrowing acceptable Addresses for Service on agency filings; the Federal Circuit affirms a $90 million infringement verdict against GlaxoSmithKline’s sale of Ellipta inhalers, and rules… [read post]
19 Nov 2020, 3:18 pm by Lawrence B. Ebert
GSK lost its appeal at the CAFC: Following trial, a jury in the United States District Court for the District of Delaware found that defendants GlaxoSmithKline LLC and Glaxo Group Limited (collectively, “GSK”) infringed U.S. [read post]
13 Nov 2020, 2:21 pm by Financial Times
Enlarge / President Donald Trump listens as Moncef Slaoui, the former head of GlaxoSmithKlines vaccines division, speaks about coronavirus vaccine development in the Rose Garden of the White House on May 15, 2020 in Washington, DC. [read post]